Entrada Therapeutics
TRDA
#7493
Rank
โ‚น25.51 B
Marketcap
โ‚น678.73
Share price
-1.00%
Change (1 day)
-41.21%
Change (1 year)

Revenue for Entrada Therapeutics (TRDA)

Revenue in 2024 (TTM): โ‚น17.67 Billion

According to Entrada Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น18.01 Billion. an increase over the revenue in the year 2023 that were of โ‚น10.74 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Entrada Therapeutics from 2021 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น18.08 B68.36%
2023 โ‚น10.74 B
2022 N/A
2021 N/A